Casey M Tansey
CIK 1474322 · last filed 2026-10-06
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
INSP price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
MENLO PARK, CA 94025
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SI | Director | 139,031 | $20.54 | $2.86M | $600.0K | 3 | 2026-10-06 |
| MOBI | Director | 632,422 | $11.19 | $7.08M | $2.00M | 3 | 2026-08-20 |
| INSP | Director | 27,132 | $63.98 | $1.74M | -$14.14M | 47 | 2026-07-17 |
| HTFL | Director | 3,089,206 | $52.40 | $161.87M | $0 | 2 | 2026-06-18 |
| eFFECTOR Therapeutics, Inc. (EFTRW) Delisted | 10%+ Owner | 136,507 | $0.00 | $82 | -$59.5K | 1 | 2022-05-19 |
| ON24 INC. (ONTF) Delisted | 10%+ Owner | 7,368,405 | $8.10 | $59.68M | $250.0K | 1 | 2021-02-05 |
| ARS Pharmaceuticals, Inc. (SBTX) Delisted | 10%+ Owner | 105,012 | $5.87 | $616.4K | $1000.0K | 1 | 2020-12-08 |
| INTERMOLECULAR INC (IMI) Delisted | 10%+ Owner | 0 | — | — | -$4.3K | 1 | 2018-11-13 |
| Intersect ENT, Inc. (XENT) Delisted | Director | 2,546 | $28.24 | $71.9K | $0 | 9 | 2017-06-05 |
| BOX | 10%+ Owner | 11,713,775 | $41.95 | $491.39M | $0 | 1 | 2015-01-30 |
| GWRE | 10%+ Owner | 4,972,862 | $161.41 | $802.67M | -$787.7K | 3 | 2012-09-25 |
| MXL | 10%+ Owner | 0 | $49.18 | $0 | -$46.5K | 3 | 2012-08-22 |
| IMPERVA INC (IMPV) Delisted | 10%+ Owner | 18,604 | — | — | $0 | 1 | 2011-11-15 |
Recent Filings · Page 8 of 8
76 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2012-09-18 | GWRE | Sell (S) | −25,191 | -$787.7K | EDGAR |
| 2012-09-12 | GWRE | Other (J) | −1,762,895 | $0 | EDGAR |
| 2012-08-22 | MXL | Sell (S) | — | $0 | EDGAR |
| 2011-11-15 | IMPERVA INC (IMPV) Delisted | Conv (C) | +1,972,824 | $0 | EDGAR |
| 2010-11-30 | MXL | Sell (S) | −4,415 | -$46.5K | EDGAR |
| 2010-03-29 | MXL | Conv (C) | +5,435,158 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.